Medexus Strengthens Balance Sheet with US$18 Million Commitment Under Accordion Facility
Medexus expects net proceeds, together with projected cash on hand, to fully satisfy convertible debentures in cash at maturity in...
Year: 2023
Satellos Expands Leadership Team with New CFO Appointment
Elizabeth Williams, CPA, CA, joins as CFO, bringing extensive expertise leading corporate finance and strategy for public biotech companies listed...
Skye Bioscience to Present at H.C. Wainwright 25th Annual Global Investment Conference
San Diego, California--(Newsfile Corp. - September 5, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a pharmaceutical company developing proprietary...
Blackrock Health Announces €25 Million Investment In New Digital Transformation Programme Creating 60 Jobs
The group has selected MEDITECH Expanse as its electronic health record system. Blackrock Health will also introduce Ireland’s first integrated...
MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
Genetic Discovery: MindBio's genetic testing in clinical research yields novel discovery for targeted diagnosis and treatmentSignificant Intellectual Property & Know...
Defence’s Innovative Therapeutics Featured on Viewpoint with Dennis Quaid
Vancouver, British Columbia--(Newsfile Corp. - September 5, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
Occlutech Q2 2023 – Continued strong revenue growth
SCHAFFHAUSEN, CH / ACCESSWIRE / September 05, 2023 / Occlutech Holding AG Occlutech Holding AG (Occlutech) is a leading specialist...
Angle PLC Announces ANGLE launch of Portrait Flex assay
LAUNCH OF PORTRAIT FLEX CIRCULATING TUMOR CELL ASSAYThe Portrait Flex assay provides tailored analyses performed as a service by ANGLE's...
Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress
New interim data from ongoing Phase 2b X-TOLE open-label extension demonstrates improvement in overall quality-of-life (QoL) when compared to baseline...
AQ Pharmaceuticals, Inc. Announces Results of JBA Brands GlucoTrojan (R) Study: Findings Show Reduction in Sugar Absorption
GARDEN GROVE, CA / ACCESSWIRE / September 3, 2023 / Affordable Quality Pharmaceuticals (AQP), established in 2000, has developed a...
Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update
Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position...
Retirement of Chandra Panchal, PhD from the Board of Directors
TORONTO, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a...
Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company,...
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...
Personalized Analysis From Breath Hub Redefines the Power of Breathwork
New research from the only app offering personalized breathwork analysis proves a science-based approach is the quickest way to help...
Constellation Behavioral Health Welcomes New Executive Vice President of Business Development Rick Hubbard
Rick is an advocate, mentor, and trusted advisor with national reach, and we are thrilled to welcome him to our...
Calm Waters AI Named Finalist for 2023 Technology Startup Award
NASHVILLE, Tenn.--(BUSINESS WIRE)--Calm Waters AI—an AI-driven technology solution that optimizes Evaluation and Management (E/M) coding for healthcare providers—has been named...
Walgreens Boots Alliance Announces Leadership Transition
Rosalind Brewer Steps Down as CEO and Member of the Board Ginger Graham, Current Lead Independent Director, Appointed Interim CEO...
Nexcella Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma...
Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma...